Tianjin Pharmaceutical Da Ren Tang Co., Ltd. (600329)
Market Open
11 Aug, 06:57
SSE SSE Primary 
SGX ¥
37. 35
+0.14
+0.3762%
¥
22.62B Market Cap
- P/E Ratio
0.6% Div Yield
777,500 Volume
- Eps
¥ 37.21
Previous Close Want to track 600329 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.12 |
| | | - | 0.18 |
| | | - | 0.16 |
| | | - | 0.15 |
| | | - | 0.13 |
| | | - | 0.16 |
| | | - | 0.16 |
| | | 0.22 | 0.13 |
| | | 0.18 | 0.08 |
| | | 0.15 | 0.13 |
| | | - | 0.14 |
| | | - | 0.16 |
| | | - | 0.06 |
| | | - | 0.1 |
| | | - | 0.16 |
| | | - | 0.09 |
600329 Earnings Reports FAQ
What is the earnings per share (EPS) for 600329?
EPS data for 600329 is currently not available, as Tianjin Pharmaceutical Da Ren Tang Co., Ltd has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 12 years, the earnings growth rate has been approximately 7.54%, reflecting the 600329's performance and SSE market conditions.
When is the next earnings release date?
Tianjin Pharmaceutical Da Ren Tang Co., Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Tianjin Pharmaceutical Da Ren Tang Co., Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 600329 at this time, as Tianjin Pharmaceutical Da Ren Tang Co., Ltd has no recent EPS data to calculate it.
